Rui Avelar
2018
In 2018, Rui Avelar earned a total compensation of $3.2M as Chief Medical Officer and Head of Research and Development at Evolus.
Compensation breakdown
| Non-Equity Incentive Plan | $160,000 |
|---|---|
| Option Awards | $1,425,752 |
| Salary | $367,885 |
| Stock Awards | $1,202,688 |
| Total | $3,156,325 |
Avelar received $1.4M in option awards, accounting for 45% of the total pay in 2018.
Avelar also received $160K in non-equity incentive plan, $367.9K in salary and $1.2M in stock awards.
Rankings
In 2018, Rui Avelar's compensation ranked 3,660th out of 14,244 executives tracked by ExecPay. In other words, Avelar earned more than 74.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,660 out of 14,244 | 74th |
Division Manufacturing | 1,355 out of 5,765 | 77th |
Major group Chemicals And Allied Products | 481 out of 2,128 | 77th |
Industry group Drugs | 400 out of 1,817 | 78th |
Industry Pharmaceutical Preparations | 308 out of 1,391 | 78th |
Source: SEC filing on March 17, 2020.
Avelar's colleagues
We found four more compensation records of executives who worked with Rui Avelar at Evolus in 2018.